Carregant...
The differentiation of pancreatic tumor-initiating cells by vitronectin can be blocked by Cilengitide
OBJECTIVE: Pancreatic cancer is a leading cancer type and its molecular pathology is poorly understood. The only potentially curative therapeutic option available is complete surgical resection; however, this is inadequate as a majority of patients are diagnosed at an advanced or metastatic stage. T...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3676482/ https://ncbi.nlm.nih.gov/pubmed/23462327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0b013e318279d568 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|